Vortioxetine - pharmacological properties and use in mood disorders. The current state of knowledge.
More details
Hide details
Katedra Psychiatrii, Collegium Medicum Uniwersytetu Jagiellońskiego, Kraków, Polska
Zakład Zaburzeń Afektywnych, Katedra Psychiatrii UJ CM
Marcin Siwek   

Zakład Zaburzeń Afektywnych, Katedra Psychiatrii UJ CM
Submission date: 2022-04-27
Final revision date: 2022-05-06
Acceptance date: 2022-06-23
Online publication date: 2022-08-19
Vortioxetine is an antidepressant with a unique profile of receptor activity. The pharmacodynamic spectrum of vortioxetine activity is linked to the modulation of not only serotoninergic but also noradrenergic and dopaminergic transmission. At the same time, its pharmacokinetic properties determine the good tolerance and safety, which are also observed in the elderly patients and those burdened with somatic comorbidity. This work aims to sum up the knowledge coming from the most recent studies assessing the efficacy of vortioxetine. The efficacy of vortioxetine in the treatment of depression was confirmed in a large number of open studies, randomized controlled studies with placebo control and meta-analyses thereof. What is more, latest research shows that this drug allows depressed patients to achieve not only symptomatic remission but also an improvement of anhedonia as well as recovery in cognitive and occupational function. Furthermore there are studies showing that vortioxetine is efficacious in the treatment of subjects who experienced trauma, suffer from bipolar depression and elderly patients. Vortioxetine is characterized by good tolerance profile and safety, rarely does it cause severe adverse effects.